Waters Corporation (WAT)

$315.92

+6.88

(+2.23%)▲

Market is closed - opens 7 PM, 02 May 2024

Insights on Waters Corporation

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 711.69M → 819.47M (in $), with an average increase of 13.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 134.55M → 216.20M (in $), with an average increase of 37.8% per quarter

  • Vs IQV

    In the last 1 year, Iqvia Holdings Inc. has given 22.0% return, outperforming this stock by 18.4%

Performance

  • $308.21
    $321.79
    $315.92
    downward going graph

    2.44%

    Downside

    Day's Volatility :4.22%

    Upside

    1.82%

    downward going graph
  • $231.90
    $363.80
    $315.92
    downward going graph

    26.6%

    Downside

    52 Weeks Volatility :36.26%

    Upside

    13.16%

    downward going graph

Returns

PeriodWaters CorporationSector (Health Care)S&P500
3 Months
-4.75%
-1.3%
2.6%
6 Months
28.32%
12.4%
18.8%
1 Year
3.63%
4.6%
20.8%
3 Years
2.44%
15.7%
20.4%

Highlights

Market Capitalization
18.5B
Book Value
$19.44
Earnings Per Share (EPS)
10.85
PE Ratio
28.69
PEG Ratio
3.13
Wall Street Target Price
326.94
Profit Margin
21.72%
Operating Margin TTM
36.96%
Return On Assets TTM
13.54%
Return On Equity TTM
77.62%
Revenue TTM
3.0B
Revenue Per Share TTM
50.04
Quarterly Revenue Growth YOY
-4.5%
Gross Profit TTM
1.7B
EBITDA
1.0B
Diluted Eps TTM
10.85
Quarterly Earnings Growth YOY
-0.04
EPS Estimate Current Year
11.89
EPS Estimate Next Year
13.14
EPS Estimate Current Quarter
3.55
EPS Estimate Next Quarter
2.39

Analyst Recommendation

Hold
    0
    0%Buy
    80%Hold
    19%Sell
Based on 26 Wall street analysts offering stock ratings for Waters Corporation(by analysts ranked 0 to 5 stars)
Based on 26 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
4
Hold
21
21
20
Sell
5
5
00

Analyst Forecast

What analysts predicted

Upside of 3.49%

Current $315.92
Target $326.94

Company Financials

FY18Y/Y Change
Revenue
2.4B
↑ 4.8%
Net Income
593.8M
↑ 2823.51%
Net Profit Margin
24.54%
↑ 23.66%
FY19Y/Y Change
Revenue
2.4B
↓ 0.55%
Net Income
592.2M
↓ 0.27%
Net Profit Margin
24.61%
↑ 0.07%
FY20Y/Y Change
Revenue
2.4B
↓ 1.71%
Net Income
521.6M
↓ 11.93%
Net Profit Margin
22.05%
↓ 2.56%
FY21Y/Y Change
Revenue
2.8B
↑ 17.78%
Net Income
692.8M
↑ 32.84%
Net Profit Margin
24.87%
↑ 2.82%
FY22Y/Y Change
Revenue
3.0B
↑ 6.68%
Net Income
707.8M
↑ 2.15%
Net Profit Margin
23.81%
↓ 1.06%
FY23Y/Y Change
Revenue
3.0B
↓ 0.52%
Net Income
642.2M
↓ 9.26%
Net Profit Margin
21.72%
↓ 2.09%
Q3 FY22Q/Q Change
Revenue
708.6M
↓ 0.81%
Net Income
156.0M
↓ 5.38%
Net Profit Margin
22.02%
↓ 1.06%
Q4 FY22Q/Q Change
Revenue
858.5M
↑ 21.16%
Net Income
227.1M
↑ 45.55%
Net Profit Margin
26.45%
↑ 4.43%
Q1 FY23Q/Q Change
Revenue
684.7M
↓ 20.25%
Net Income
140.9M
↓ 37.94%
Net Profit Margin
20.58%
↓ 5.87%
Q2 FY23Q/Q Change
Revenue
740.6M
↑ 8.16%
Net Income
150.6M
↑ 6.83%
Net Profit Margin
20.33%
↓ 0.25%
Q3 FY23Q/Q Change
Revenue
711.7M
↓ 3.9%
Net Income
134.6M
↓ 10.63%
Net Profit Margin
18.91%
↓ 1.42%
Q4 FY23Q/Q Change
Revenue
819.5M
↑ 15.14%
Net Income
216.2M
↑ 60.69%
Net Profit Margin
26.38%
↑ 7.47%
FY18Y/Y Change
Total Assets
3.7B
↓ 30.19%
Total Liabilities
2.2B
↓ 30.44%
FY19Y/Y Change
Total Assets
2.6B
↓ 31.4%
Total Liabilities
2.8B
↑ 28.39%
FY20Y/Y Change
Total Assets
2.8B
↑ 11.06%
Total Liabilities
2.6B
↓ 5.97%
FY21Y/Y Change
Total Assets
3.1B
↑ 8.98%
Total Liabilities
2.7B
↑ 4.59%
FY22Y/Y Change
Total Assets
3.3B
↑ 6.03%
Total Liabilities
2.8B
↑ 1.82%
FY23Y/Y Change
Total Assets
4.6B
↑ 41.0%
Total Liabilities
3.5B
↑ 25.19%
Q3 FY22Q/Q Change
Total Assets
3.1B
↑ 0.97%
Total Liabilities
2.7B
↑ 1.37%
Q4 FY22Q/Q Change
Total Assets
3.3B
↑ 6.89%
Total Liabilities
2.8B
↑ 3.43%
Q1 FY23Q/Q Change
Total Assets
3.3B
↑ 0.77%
Total Liabilities
2.7B
↓ 2.52%
Q2 FY23Q/Q Change
Total Assets
4.5B
↑ 37.54%
Total Liabilities
3.8B
↑ 39.53%
Q3 FY23Q/Q Change
Total Assets
4.5B
↓ 1.12%
Total Liabilities
3.6B
↓ 4.91%
Q4 FY23Q/Q Change
Total Assets
4.6B
↑ 2.88%
Total Liabilities
3.5B
↓ 3.21%
FY18Y/Y Change
Operating Cash Flow
604.4M
↓ 13.36%
Investing Cash Flow
1.7B
↓ 414.19%
Financing Cash Flow
-2.1B
↑ 3218.55%
FY19Y/Y Change
Operating Cash Flow
643.1M
↑ 6.39%
Investing Cash Flow
768.8M
↓ 54.33%
Financing Cash Flow
-1.9B
↓ 11.65%
FY20Y/Y Change
Operating Cash Flow
790.5M
↑ 22.92%
Investing Cash Flow
-264.1M
↓ 134.35%
Financing Cash Flow
-440.5M
↓ 76.48%
FY21Y/Y Change
Operating Cash Flow
747.3M
↓ 5.47%
Investing Cash Flow
-231.6M
↓ 12.29%
Financing Cash Flow
-438.3M
↓ 0.51%
FY22Y/Y Change
Operating Cash Flow
611.7M
↓ 18.15%
Investing Cash Flow
-108.0M
↓ 53.39%
Financing Cash Flow
-509.6M
↑ 16.28%
Q3 FY22Q/Q Change
Operating Cash Flow
158.1M
↑ 177.46%
Investing Cash Flow
-38.4M
↑ 105.58%
Financing Cash Flow
-88.0M
↑ 6.33%
Q4 FY22Q/Q Change
Operating Cash Flow
198.7M
↑ 25.69%
Investing Cash Flow
-108.0M
↑ 181.31%
Financing Cash Flow
-111.4M
↑ 26.63%
Q1 FY23Q/Q Change
Operating Cash Flow
196.8M
↓ 0.99%
Investing Cash Flow
-34.4M
↓ 68.13%
Financing Cash Flow
-159.2M
↑ 42.86%
Q2 FY23Q/Q Change
Operating Cash Flow
18.1M
↓ 90.79%
Investing Cash Flow
-1.4B
↑ 3872.91%
Financing Cash Flow
1.2B
↓ 827.45%
Q3 FY23Q/Q Change
Operating Cash Flow
157.8M
↑ 771.06%
Investing Cash Flow
-1.4B
↑ 2.74%
Financing Cash Flow
-113.5M
↓ 109.8%

Technicals Summary

Sell

Neutral

Buy

Waters Corporation is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Waters Corporation
Waters Corporation
-10.3%
28.32%
3.63%
2.44%
46.08%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
-7.45%
24.64%
0.65%
-10.39%
110.53%
Agilent Technologies Inc.
Agilent Technologies Inc.
-5.85%
33.23%
0.71%
2.89%
76.89%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
-1.51%
28.93%
3.69%
21.68%
105.69%
Danaher Corp.
Danaher Corp.
-0.47%
29.8%
2.02%
-3.16%
87.46%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
-6.87%
28.75%
21.98%
-0.94%
71.69%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Waters Corporation
Waters Corporation
28.69
28.69
3.13
11.89
0.78
0.14
NA
19.44
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
49.03
49.03
4.75
11.13
0.81
0.23
NA
17.88
Agilent Technologies Inc.
Agilent Technologies Inc.
32.89
32.89
2.7
5.5
0.21
0.08
0.01
21.12
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
37.35
37.35
2.81
21.53
0.13
0.05
0.0
120.87
Danaher Corp.
Danaher Corp.
45.86
45.86
3.13
7.63
0.08
0.04
0.0
72.16
Iqvia Holdings Inc.
Iqvia Holdings Inc.
32.18
32.18
1.33
11.11
0.23
0.05
NA
33.67
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Waters Corporation
Waters Corporation
Hold
$18.5B
46.08%
28.69
21.72%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
Buy
$41.1B
110.53%
49.03
23.08%
Agilent Technologies Inc.
Agilent Technologies Inc.
Buy
$40.8B
76.89%
32.89
18.35%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Buy
$220.4B
105.69%
37.35
13.99%
Danaher Corp.
Danaher Corp.
Buy
$185.5B
87.46%
45.86
18.55%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
Buy
$42.8B
71.69%
32.18
9.06%

Institutional Holdings

  • Vanguard Group Inc

    11.53%

  • BlackRock Inc

    9.50%

  • Fundsmith LLP

    6.41%

  • Bank of New York Mellon Corp

    5.83%

  • Massachusetts Financial Services Company

    5.15%

  • State Street Corporation

    4.24%

Company Information

waters corporation (nyse: wat), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years. with approximately 7,000 employees worldwide, waters operates directly in 31 countries, including 15 manufacturing facilities, and with products available in more than 100 countries. waters corporation's businesses include waters, ta instruments, vicam, era, and nonlinear dynamics. waters creates business advantages for laboratory-dependent organizations by delivering ultra performance liquid chromatography (uplc), high-performance liquid chromatography (hplc), chromatography columns and chemistry products, mass spectrometry systems, laboratory informatics solutions, and comprehensive service programs to enable significant advancement in healthcare delivery, environmental management, food safety, and water quality. ta instruments'​ thermal analysis, rheometry

Organization
Waters Corporation
Employees
7900
CEO
Dr. Udit Batra Ph.D.
Industry
Health Technology

Discover More

FAQs